Related Experiment Videos
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria
B S Kristal1, A D Conway, A M Brown
1Dementia Research Service, Burke Medical Research Institute, White Plains, NY 10605, USA. bkristal@burke.org
Free Radical Biology & Medicine
|April 11, 2001
Summary
The Parkinson's disease drug L-DOPA may worsen the condition by producing a toxic metabolite, DOPAL. This metabolite, 3,4-dihydroxyphenylacetaldehyde (DOPAL), triggers cell death in mitochondria, particularly when they are energetically compromised.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Pharmacology
Background:
- Parkinson's disease (PD) affects nearly 1% of individuals aged 70-79 and 2.5% of those aged 85.
- L-DOPA is the primary treatment for PD but may contribute to disease progression.
- Mechanisms of selective dopaminergic neuron loss in aging and neurodegenerative diseases are not fully understood.
Purpose of the Study:
- To investigate the cytotoxic effects of dopamine metabolites, particularly 3,4-dihydroxyphenylacetaldehyde (DOPAL).
- To elucidate the role of mitochondrial function in dopaminergic neurotoxicity.
- To explore potential mechanisms underlying L-DOPA-mediated neurotoxicity.
Main Methods:
- Utilized neuronally differentiated PC12 cells to assess cytotoxicity.
- Examined the effect of DOPAL on isolated, energetically compromised mitochondria.
- Investigated the impact of mitochondrial respiration and permeability transition (PT) inhibitors on DOPAL-induced cell death.
Main Results:
- 3,4-dihydroxyphenylacetaldehyde (DOPAL) demonstrated significantly higher cytotoxicity than dopamine and its other metabolites in PC12 cells.
- Physiological concentrations of DOPAL induced mitochondrial permeability transition (PT) in energetically compromised mitochondria.
- Dopamine was over 1000-fold less potent than DOPAL in inducing PT.
- PT inhibitors protected both mitochondria and cells from DOPAL toxicity.
- Mitochondrial respiration increased resistance to DOPAL-induced PT by at least 30-fold.
Conclusions:
- DOPAL, a metabolite of dopamine, is a potent inducer of mitochondrial permeability transition and cell death.
- Energetically compromised mitochondria are particularly vulnerable to DOPAL.
- Mitochondrial respiration may confer resistance to endogenous DOPAL in the substantia nigra.
- These findings suggest a potential mechanism for L-DOPA-induced neurotoxicity and selective neuronal vulnerability in Parkinson's disease.